Answers are grounded in this paper and cite their sources.
This analysis of MOMENTUM 3 suggests that younger age (≤65 years) at implant and pump choice are associated with a greater likelihood of primary end-point success. These findings further suggest that characterization of therapeutic intent into discrete bridge-to-transplant and destination therapy categories offers no clear clinical advantage, and should ideally be abandoned.
No takes yet. Share an insight, caveat, or question.
Goldstein et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: